| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |